300363 博腾股份
已收盘 04-30 15:00:00
资讯
新帖
简况
开源证券:给予博腾股份买入评级
证券之星 · 04-30 16:43
开源证券:给予博腾股份买入评级
博腾股份(300363.SZ)全资子公司通过美国FDA现场检查
智通财经网 · 2023-11-20
博腾股份(300363.SZ)全资子公司通过美国FDA现场检查
加载更多
公司概况
公司名称:
重庆博腾制药科技股份有限公司
所属行业:
医药制造业
上市日期:
2014-01-29
主营业务:
重庆博腾制药科技股份有限公司的主营业务是化学原料药CDMO、化学制剂CDMO、生物CDMO业务。主要致力于为全球制药公司、新药研发机构等提供从临床前到临床试验直至药品上市全生命周期所需的化学原料药、化学制剂及生物药的定制研发和定制生产服务,包括但不限于工艺路线设计、开发及优化,分析方法开发,工艺和分析验证,工艺安全性评估,质量研究,实验室小试、中试、商业化生产等。
发行价格:
25.10
{"stockData":{"symbol":"300363","market":"SZ","secType":"STK","nameCN":"博腾股份","latestPrice":16.81,"timestamp":1714460604000,"preClose":17.1,"halted":0,"volume":8526220,"delay":0,"floatShares":501000000,"shares":546000000,"eps":-0.242,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.29,"latestTime":"04-30 15:00:00","open":17.1,"high":17.15,"low":16.6,"amount":143000000,"amplitude":0.0322,"askPrice":16.81,"askSize":75,"bidPrice":16.8,"bidSize":344,"shortable":0,"etf":0,"ttmEps":-0.242,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":17.1,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":18.81,"lowLimit":15.39,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":546037820,"pbRate":1.64,"roa":"--","roe":"--","epsLYR":0.49,"committee":0.004292,"marketValue":9179000000,"floatMarketCap":8413000000,"peRate":-69.46281,"changeRate":-0.017,"turnoverRate":0.017,"status":1},"requestUrl":"/m/hq/s/300363","defaultTab":"news","newsList":[{"id":"2431959063","title":"开源证券:给予博腾股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431959063","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431959063?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:43","pubTimestamp":1714466631,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,汪晋近期对博腾股份进行研究并发布了研究报告《公司信息更新报告:常规业务增速稳健,利润端阶段性承压》,本报告对博腾股份给出买入评级,当前股价为16.81元。CGT业务引入新客户54家、新项目83个,新签订单1.35亿元。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级3家,增持评级2家;过去90天内机构目标均价为20.3。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000034878.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2384534288","title":"博腾股份(300363.SZ)全资子公司通过美国FDA现场检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2384534288","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2384534288?lang=zh_cn&edition=full","pubTime":"2023-11-20 18:09","pubTimestamp":1700474940,"startTime":"0","endTime":"0","summary":"博腾股份(300363.SZ)公告,公司全资子公司江西博腾药业有限公司(“江西博腾”)于2023年8月21日至25日接受了美国食品药品监督管理局(“FDA”)的现场检查,检查范围涵盖质量、生产、设备设施、实验室控制、物料及包装标签等六大体系。近日,江西博腾收到FDA出具的现场检查报告(EIR,Establishment Inspection Repor),确认本次检查已结束,江西博腾通过现场检查。\n\n现在送您60元福利红包,直接提现不套路~~~快来参与活动吧!\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-20/doc-imzvhhxp4004441.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-20/doc-imzvhhxp4004441.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2014-01-29","address":"重庆市长寿区化工园区精细化工一区","stockEarnings":[{"period":"1week","weight":0.0231},{"period":"1month","weight":-0.0609},{"period":"3month","weight":-0.0524},{"period":"6month","weight":-0.4338},{"period":"1year","weight":-0.4937},{"period":"ytd","weight":-0.3316}],"companyName":"重庆博腾制药科技股份有限公司","boardCode":"AI0027","perCapita":"9602股","boardName":"医药制造业","registeredCapital":"54603万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 重庆博腾制药科技股份有限公司的主营业务是化学原料药CDMO、化学制剂CDMO、生物CDMO业务。主要致力于为全球制药公司、新药研发机构等提供从临床前到临床试验直至药品上市全生命周期所需的化学原料药、化学制剂及生物药的定制研发和定制生产服务,包括但不限于工艺路线设计、开发及优化,分析方法开发,工艺和分析验证,工艺安全性评估,质量研究,实验室小试、中试、商业化生产等。","serverTime":1714633869491,"listedPrice":25.1,"stockholders":"52120人(较上一季度减少1.52%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博腾股份(300363)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博腾股份(300363)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博腾股份,300363,博腾股份股票,博腾股份股票老虎,博腾股份股票老虎国际,博腾股份行情,博腾股份股票行情,博腾股份股价,博腾股份股市,博腾股份股票价格,博腾股份股票交易,博腾股份股票购买,博腾股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博腾股份(300363)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博腾股份(300363)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}